Wed, February 1, 2023
Tue, January 31, 2023
Mon, January 30, 2023
Sun, January 29, 2023
Fri, January 27, 2023

Geulah Livshits Maintained (SNTI) at Strong Buy with Decreased Target to $80 on, Jan 30th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-80-on-jan-30th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Geulah Livshits of Chardan Capital, Maintained "Senti Biosciences, Inc." (SNTI) at Strong Buy with Decreased Target from $120 to $80 on, Jan 30th, 2023.

Geulah has made no other calls on SNTI in the last 4 months.



There are 2 other peers that have a rating on SNTI. Out of the 2 peers that are also analyzing SNTI, all agree with Geulah's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $30 on, Friday, January 27th, 2023
  • Brian Cheng of "JP Morgan" Initiated at Hold on, Friday, December 16th, 2022

Publication Contributing Sources